CA2371611A1 - Galectine 11 - Google Patents
Galectine 11 Download PDFInfo
- Publication number
- CA2371611A1 CA2371611A1 CA002371611A CA2371611A CA2371611A1 CA 2371611 A1 CA2371611 A1 CA 2371611A1 CA 002371611 A CA002371611 A CA 002371611A CA 2371611 A CA2371611 A CA 2371611A CA 2371611 A1 CA2371611 A1 CA 2371611A1
- Authority
- CA
- Canada
- Prior art keywords
- polypeptide
- galectin
- amino acid
- replaced
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4726—Lectins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Publié sans précis
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13039099P | 1999-04-21 | 1999-04-21 | |
US60/130,390 | 1999-04-21 | ||
US16993299P | 1999-12-10 | 1999-12-10 | |
US60/169,932 | 1999-12-10 | ||
PCT/US2000/010714 WO2000063221A2 (fr) | 1999-04-21 | 2000-04-21 | Galectine 11 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2371611A1 true CA2371611A1 (fr) | 2000-10-26 |
Family
ID=26828443
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002371611A Abandoned CA2371611A1 (fr) | 1999-04-21 | 2000-04-21 | Galectine 11 |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1192168A4 (fr) |
JP (1) | JP2002541832A (fr) |
AU (1) | AU4365800A (fr) |
CA (1) | CA2371611A1 (fr) |
WO (1) | WO2000063221A2 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6605699B1 (en) | 1997-01-21 | 2003-08-12 | Human Genome Sciences, Inc. | Galectin-11 polypeptides |
AU4969599A (en) * | 1998-07-06 | 2000-01-24 | Human Genome Sciences, Inc. | Galectin 11 |
JP4904153B2 (ja) | 2003-06-20 | 2012-03-28 | アキシオジェネシス エージー | 胚性幹(es)細胞系での組織モデリング |
CA2559791A1 (fr) | 2003-07-08 | 2005-01-20 | Axiogenesis Ag | Proteines secretees utilisees en tant que marqueurs de differenciation cellulaire |
CA2560334A1 (fr) | 2004-04-07 | 2005-10-20 | Axiogenesis Ag | Systemes de dosage tissulaire fonctionnel in vitro, non invasifs |
CA2565858C (fr) | 2004-05-11 | 2021-06-22 | Axiogenesis Ag | Dosage pour la decouverte de medicament reposant sur des cellules differenciees in vitro |
WO2008013082A1 (fr) * | 2006-07-25 | 2008-01-31 | Galpharma Co., Ltd. | Conjugué galectine 9/polymère |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0972022A2 (fr) * | 1997-01-21 | 2000-01-19 | Human Genome Sciences, Inc. | Polynucleotides et polypeptides codant des recepteurs |
AU4969599A (en) * | 1998-07-06 | 2000-01-24 | Human Genome Sciences, Inc. | Galectin 11 |
US6168920B1 (en) * | 1998-08-10 | 2001-01-02 | Incyte Genomics, Inc. | Extracellular adhesive proteins |
-
2000
- 2000-04-21 WO PCT/US2000/010714 patent/WO2000063221A2/fr not_active Application Discontinuation
- 2000-04-21 CA CA002371611A patent/CA2371611A1/fr not_active Abandoned
- 2000-04-21 EP EP00923556A patent/EP1192168A4/fr not_active Withdrawn
- 2000-04-21 JP JP2000612311A patent/JP2002541832A/ja not_active Withdrawn
- 2000-04-21 AU AU43658/00A patent/AU4365800A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2002541832A (ja) | 2002-12-10 |
EP1192168A1 (fr) | 2002-04-03 |
AU4365800A (en) | 2000-11-02 |
EP1192168A4 (fr) | 2003-04-16 |
WO2000063221A2 (fr) | 2000-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6605699B1 (en) | Galectin-11 polypeptides | |
US7208470B2 (en) | Method of treating reproductive system cancer by administering follistatin-3 | |
US6593112B1 (en) | Polynucleotides encoding fibroblast growth factor 15 | |
US6537966B1 (en) | Follistatin-3 | |
JP2003512815A (ja) | ヒト乳癌および卵巣癌関連遺伝子配列およびポリペプチド | |
US6605441B1 (en) | Antibodies against fibroblast growth factor 11 | |
US6824993B2 (en) | Antibodies that bind human prostate specific G-protein receptor HPRAJ70 | |
CA2387685A1 (fr) | Proteines et acides nucleiques de stanniocalcine et methodes afferentes | |
CA2385487A1 (fr) | 13 proteines associees au cancer du colon et au colon humain | |
CA2371114A1 (fr) | Recepteurs contenant un domaine de mort cellulaire | |
CA2371611A1 (fr) | Galectine 11 | |
US20050019824A1 (en) | Fibroblast Growth Factor-10 | |
US6849413B2 (en) | PGRP-L polynucleotides, polypeptides, and antibodies | |
CA2373616A1 (fr) | Recepteurs tm4sf | |
EP1203018A1 (fr) | Prostate humaine 26 et cancer de la prostate associe aux proteines | |
US20020025553A1 (en) | Transforming growth factor alpha HIII | |
AU7354700A (en) | Human neuropeptide receptor | |
US20030175778A1 (en) | Interferon Receptor HKAEF92 | |
CA2382659A1 (fr) | Molecule d'activation lymphocytaire secretee de maniere enrichie par des cellules dendritiques | |
WO2000071152A1 (fr) | Facteur 10 de croissance des fibroblastes | |
EP1248801A1 (fr) | Polynucleotides, polypeptides et anticorps humains | |
WO2000071715A1 (fr) | Facteur 11 de croissance des fibroblastes | |
WO2000067775A1 (fr) | Facteur de croissance des fibroblastes (fgf) 15 | |
WO2000071582A1 (fr) | Facteur 14 de croissance du fibroblaste | |
CA2422642A1 (fr) | Recepteur hpraj70 de la proteine g specifique de la prostate humaine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |